Bauke te Nijenhuis*
International Bio-SyntheticsB.V.,Patentlaan 3, NL-2288 EE Rijswijk,The Netherlands
When we discuss biotechnology we have to realize that this sector is not only one
of the most rapidly growing areas in industry, but also is one of the oldest technolo-
gies 'in human history.
Biotechnology by definition is the integration of the basic disciplines bio-
chemistry, genetics, microbiology and process technology in biological systems on
behalf of industrial processes and the environment. This definition not only includes
the activities of the traditional fermentation industry, but gives also entrance to new
fields of biotechnology as commercialized plant tissue culture, its use for production
of important plant related chemical compounds, the use of animal, more specifically
mammalian cells for special purposes and the rapidly growing field of monoclonal
antibodies.
More than 10000 years ago biochemical processes were already used for spon-
taneous fermentation of food, resulting in better digestibility, better taste, improved
stability and tenability, etc. Just think of the leavening of bread and the production
of a wide variety of fermented food and beverages.
Biocatalysis~ Immuno-analysis
R-DNA: Ani
ir'DNA-probes
Bio-sensors
Analytical
chemistry x x x x x x x x x x x x x x x x x x x x x x
Classical
microbiology xx x xx x xx xx x xx x x x? xx x
Enzymatic xx x x x x x x x? x
Immunology xx x x (x ) xx (x ) x x? x x
Biosensors (x ) (x ) (x)
DNA probes (x ) (x) x ?
Fig. 2. Current status: Technology versus application ( x x strong impact, x moderate impact,
limited impact, ( ) first product introductions). Source: Arthur D. Little (ref. [2])
What has the analytical discipline available? In the days of classical biotech-
nology and fermentation the c o m m o n physical chemical techniques were used with
an extension to microbiological methods, mainly used for contamination detection
and sometimes for activity determination. O n relatively short notice biochemical
analytical procedures have found their way into biotechnology and nowadays the
analytical range has been extended with enzymatic methods, immunology, bio-
sensors and DNA-probes, more generally called: biodetection. The current applica-
tion status is shown in Fig 2.
However, analytical chemistry is not only fast in introducing the new bio-
chemical methods in its package, but is also working very hard on applications of
existing physical chemical methods in biotechnology with surprising results. One
recognizes that modern biotechnology is not only able to produce new products for
use in society, but also capable to prepare analytical devices for testing purposes in
the biochemical discipline.
iTor more indepth information, I would like to draw your attention to a series
of symposia dedicated to "Analytical Methods in Biotechnology", the so-called
Anabiotec Symposia held in Noordwijkerhout in the Netherlands in 1984 and 1988.
This international symposium has now flown over the Atlantic and has been held in
October 1990 in San Francisco. Noordwijkerhout is the venue again in 1992 [3].
As a second option to mention is the Annual Seminars on Analytical Biotechnology
under the chairmanship of Professors Karger and Regnier, dedicated to special
subjects. This year's meeting was dedicated to monitoring of genetically engineered
product composition and purity, especially for use in the pharmaceutical drug
industry [4].
HPLC
HPLC is seen as the most powerful separation technique in the field of sciences. A
very broad supply of columns for all types of biomolecules is available [6]. High
speed separations, using short, small particle columns will become more common.
Combining HPLC with electrophoresis will be reality in future and sensitivities
enhancement will even override the femto- and attomole level.
For structural analysis, the combinations liquid chromatography (LC)-mass
spectrometry (MS) and capillary zone electrophoresis (CZE)-LC-MS seem to be the
most promising techniques of the future [7]. Interfacing is quite simple by the usage
of techniques like electrospray ionization, which can be used for both low and high
molecular weight compounds.
For therapeutic drug monitoring in the hospital, e.g. studies on effectiveness,
stability, biotransformation, excretion, etc., HPLC is the best choice because of its
relative good tolerance of complex biological matrices. In this respect HPLC can
compete with the also often used ELISA assays. Pharmaceuticals, monitored by
HPLC are tabulated by Kulinsky [8] (Fig. 3).
Chiral separations are extremely important because of the fact that as a rule only
one of the enantiomers is physiologically active. Several systems are available: chiral
stationary phase, chiral modifiers in the mobile phase or precolumn derivatisation
with chiral agents [7]. The FDA is proposing making the screening of all pharma-
ceuticals for optical activity a legal requirement.
Penicillin Verapamil
Levodopa p-Aminosalicylic
acid
Cephalosporin Imipramine
Codeine Isoniazid
Aminoglycosides Captopril
Cimetidine Trimethoprim
Chloramphenicol Extromethorphan
Acyclovir Wafarin
Erythromycin Carbamazepine
Cyclosporin Carbutamide
Tetracycline Chlorpromazine
6-Mercaptopurine Econazole
Clofibrate Benperidol
Theophyline Chloroquine
Dapsone Clonazepam Fig. 3. Pharmaceuticals assayed by HPLC. Source:
Kulinsky (ref. I-8])
Challenges in the Relation BetweenAnalysisand Biotechnology 171
Mass Spectrometry
MS has proven its applicability for both fermentation control and structure informa-
tion on biomolecules. Molecular weight information on protein up to about 25-
50000 Dalton can be obtained by means of plasma-desorption mass-spectrometry.
Sequence informative fragmentation of peptides have been reported as a joint effect
from industry (Gist-brocades, The Netherlands) and university (Leiden) [9]. PDMS
might thus become an alternative for Fast Atom Bombardment MS as tool for
protein sequencing.
Electrophoresis
Capillary electrophoresis proves to be an almost perfect separation method for
water-soluble components in small sample volumes. Three execution modes are used
in practice: capillary zone electrophoresis, capillary gel electrophoresis, and separa-
tion of unchanged molecules by complexation and inclusion methods.
Applications include separation of proteins and peptides, tryptic mapping, DNA
sequencing, serum analysis, etc. DNA sequencing is the hottest topic because of the
interest in determining the human genome [11, 12]. In combination with LC and
MS a very powerful combination can be set up.
Biosensors
Because of the still high expectations of this special area in biodetection some critical
remarks are in order. Biosensors can be defined as devices which convert biological
events into electronic output signals. A more practical definition is "biosensors are
sensors measuring in biological systems", thus including also pH and selective
electrodes in the biosensor definitions. A lot of biosensors are known. Fig. 4 gives
an overview of which various biological elements and transducers are being used in
biosensor devices.
About 100 examples have been published now, of which some 10 are commer-
cially available. Most of the applications of biosensors are in medical and clinical
diagnosis with a spin-off to biotechnology and environment [15, 17]. Although the
enthusiasm in academia is undiminished high and the expectations in the market
place also are still high, it is doubtful whether the breakthrough will come soon
[14, 16]. Usage in biotechnology looks very limited, not only because of the fact
that biosensors cannot be sterilised, but also on other unwanted properties (Fig. 5).
Radical new approaches are needed e.g. the development and incorporation of
thermostable biological compounds.
As a conclusion one can state that because of the presented constraints the
present biosensors can only be used in biotechnology in the following modes: off-line
and discontinuous, on-line after a sampling treatment, on-line behind a membrane.
Organisms Potentiometric
Tissues Amperometric
Cells Conductometric
Organelles Impedimetric
Membranes Optical
Enzymes Calorimetric
Enzyme components Acoustic
Receptors Mechanical
Antibodies "Molecular" electronic
Nucleic acids
Organic molecules Fig. 4. Components that may be used to construct
a biosensor. Source: te Nijenhuis (ref. [14])
Less stability
Response time too long
Not suitable for continuous operation
Re-usability uncertain
Fouling by clogging of particulate matters
Recalibration hardly possible
Sensitivity for pH, ionic strength, temperature Fig. 5. Disadvantages of biosensors. Source: te
Nijenhuis (ref. 1-14])
Challenges in the Relation Between Analysis and Biotechnology 173
Cooling water
Cooling
Air (inlet)
Contaminant Monitoring
"Contaminant monitoring is a small but dynamic biotechnology segment that will
grow rapidly in importance as public awareness and concern over the contamination
of food, air, soil and water increases" [4].
Conventional methods include chromatography and mass spectrometry, but
inmuno diagnostics is a rapidly growing area. Here, special attention is devoted to
another area of contaminant monitoring: purity aspects of genetically engineered
Challengesin the Relation BetweenAnalysisand Biotechnology 175
II FERMENTER l[
I
F. . . . . . . . . . . . . . . . . . . . . . . . 1
F. . . . . . . . ~-----l F. . . . . . .......... l
I GAS P ~ S E I I AQ~OUS P~SE I
L. . . . . . . . T__3 L ..... T. . . . . . . . . U
I
F- V~IOUS ~- SENSORS
I I
I I
I ~- (NIR)
I I
L_ MS I
] SAMPLING SYSTEM I
L ..... T . . . . . . . . . . . ]
I
~- SENSORS
I
I
~-~LC+DETECTORS
i
~- FIA+DETECTORS Fig. 7. Analytical systems in fer-
I
L_ MS mentation control
product compositions and the tests on absence of all kind of compounds related to
the production system: say, contaminants of the cell cultures used and the produc-
tion process. Residual DNA, protein and polysaccharides, esp. toxins subdivided in
endotoxins and mycotoxins are considered in this respect [22]. This area is not only
of analytical importance, but also highly politically influenced. The EC is very active
in this field and the European Organisation for Quality Control in Pharmaceutical
and Cosmetic Industries is trying to influence the setting of the rules in such a way
that the limits are in line with reasonable criteria and analytical feasibility.
Here once again the limits of analytical chemistry today are approached and
immense efforts have to be made in order to be capable to detect the foresaid
compounds at the desired level. It can be foreseen that the conventional methods
are not good enough for the targets set. Most probably HPLC-MS and CZE-MS
can reach the low levels asked for, next to biodetection methods.
For residual DNA commercially available systems are being tested very seri-
ously. Levels of two picogram seem to be attainable which is close to the present
demands of the FDA. For residual protein pyrochemoluminiscence is claimed to be
a good technique. Most simple, of course, is a determination in what is supposed
to be a nitrogen-free preparation, but problems arise when that is not the case. For
endotoxins the microlumilus test is a good alternative whereas for mycotoxins
immuno-assays are recommended next to GC-MS determinations.
Not explicitly touched in this contribution is the importance of quality and
consequently of validation of methods, but it is assumed that the extreme impor-
tance for research and production is generally recognized.
Conclusion
The final goal of industry and the prior research is to produce safe and effective
products which are properly controlled during the production process. To achieve
176 Challenges in the Relation Between Analysis and Biotechnology
Note
BiofineTM chemicals is a registered trademark from International Bio-Synthetics B.V. The products
involved are speciality intermediates with at least one biocatalytic transformation step during synthesis.
References
[1] R. E. Shamel, J. J. Chow, Chem. Eng. Prog. 1989, December, 33.
[2] A. D. Little, Bioteehnology and the Dutch Industry, Strategic study on behalf of Dutch Ministry
of Economic Affairs, December 1989 (in Dutch).
[3] (a) Proceedings Anabiotec 1984: Anal. Chim. Aeta 1984, 163, 1-326; (b) Proceedings Anabiotec
1988: Anal. Chim. Acta 1988, 213, 1-282.
[4] Agenda 4th Annual Seminar on Analytical Biotechnology, June 11-14, 1990, Crystal City (Arling-
ton), Virginia, USA
[5] J. L. Glajch, Anal. Chem. 1986, 58, 385A.
[6] R. E. Majors, LG/GC International 1990, 3 (4), 12; LG/GC International 1990, 3 (5), 10.
[7] R. E. Majors, LG/GC International 1989, 2 (11), 12.
[8] R. F. Kulinski, LG/GC International 1990, 3 (7), 23.
[9] M. W. E. M. van Tilborg, et al., Rap. Comm. Mass Spectr. 1990, 4, 202.
[10] I. Ogbomo, U. Prinzing, H. L. Schmidt, J. Biotechn. 1990, 14, 63.
[i1] V. Berry, LG/GC International 1990, 3 (6), 46.
[12] D. M. Goodall, D. K. Lloyd, S. J. Williams, LG/GC International 1990, 3 (7), 28.
[13I J. G. A. M. Raaijmakers, Personal communication.
[14] B. te Nijenhuis, Proceedings Eleetro Finn Analysis Conference, Turku, 1988.
[15] Bisensrs Fundamentals and Applicatins (A. P. F. TurnerI. Karube G. S. Wisn eds.) xfrd
University Press, Oxford, 1987.
[16] A. P. F. Turner, Contribution to Eurosensors II, 4th Symposium on Sensors and Actuators,
November, 1988.
[17] Proceedings Biosensor Symposium, Enschede, December, 1988.
[18] J. B. Callis, D. L. Illman, B. R. Kowalski, Anal. Chem. 1987, 59, 624A.
[19] G. Schmidt, Biotec 1990, April, 6.
[20] K. Schfigerl, T. Lorenz, A. Liibbert, J. Niehoff, T. Scheper, W. Schmidt, Trends in Biotech. 1986,
4, 11.
[21] J.G.A.M. Raaijmakers, Personal communication; Process Analysis in the Fermentation Industry
(in Dutch), (lecture presented to the Dutch Section for Analytical Chemistry), 1988.
[22] Quality Assurance in the Manufacture f Prducts Derivedfrm Bitehnly EQC Cnference
Frankfurt, December, 1988.
Lebih dari sekadar dokumen.
Temukan segala yang ditawarkan Scribd, termasuk buku dan buku audio dari penerbit-penerbit terkemuka.
Batalkan kapan saja.